The pharmacological treatment of opioid addiction--a clinical perspective.
about
Methadone at tapered doses for the management of opioid withdrawalActivation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie volesCannabinoid and opioid interactions: implications for opiate dependence and withdrawalA critical review of the literature on attentional bias in cocaine use disorder and suggestions for future researchCurrent and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.Combined abuse of clonidine and amitriptyline in a patient on buprenorphine maintenance treatment.The frequency of agitation due to inappropriate use of naltrexone in addictsDifferential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Slow-release oral morphine for opioid maintenance treatment: a systematic review.Beneficial effects of co-treatment with dextromethorphan on prenatally methadone-exposed offspringDistinct ETA receptor binding mode of macitentan as determined by site directed mutagenesisAutomated radiochemical synthesis and biodistribution of [¹¹C]l-α-acetylmethadol ([¹¹C]LAAM).Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanChronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.Addiction and brain reward and antireward pathways.The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteersAttenuation of Withdrawal Signs, Blood Cortisol, and Glucose Level with Various Dosage Regimens of Morphine after Precipitated Withdrawal Syndrome in Mice.Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in ratsPerioperative pharmacokinetics of methadone in adolescents.Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).Role of cytochrome P4502B6 in methadone metabolism and clearance.The treatment of alcohol and opioid dependence in pregnant women.Newer approaches to opioid detoxification.Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.Mechanism of autoinduction of methadone N-demethylation in human hepatocytes.High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometryNaltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.The RNA superhighway: axonal RNA trafficking of kappa opioid receptor mRNA for neurite growth.Pharmacotherapies for treating opioid use disorder.Narcotic bowel syndrome and opioid-induced constipation.Reduction of opiate withdrawal symptoms with use of clonidine in a county jail.Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder.Opioid dependence and substitution therapy: thymoquinone as potential novel supplement therapy for better outcome for methadone maintenance therapy substitution therapy.Six-month follow-up study of ultrarapid opiate detoxification with naltrexone.The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.Why Do Those With Long-Term Substance Use Disorders Stop Abusing Substances? A Qualitative Study.
P2860
Q24200729-F58EF390-3C04-4CB6-BB18-E14834F20717Q24635916-EBD7E525-16DE-42BE-A085-7924ECE85A24Q27000762-6C5A9ADA-6DFC-4B79-8025-117299AB3378Q27012850-EA0F2431-B67D-4D8A-9D50-389A3CDD6E0FQ27692554-BC84B973-FE86-4E67-B20D-A92E6E8DF537Q33815047-88371200-26A7-4713-8802-D07C85F06E82Q34490269-26120E6B-A9A2-41D0-A399-7C9103AB358DQ34813559-E801D281-0311-4BC4-8368-DA136F754208Q34973799-375C26C8-6074-44D1-B2A6-BEF7A0B96854Q34996905-DEC18ABA-3FA1-46C3-9EB3-9D4D65CE517BQ35224152-5780433C-363E-4B41-8D3B-D7FB4E0CB1A6Q35256194-525F6940-32EB-465D-914C-EC4769A4E58AQ35258947-11973422-F2AE-457F-8BB5-9ABF3176856AQ35490468-EDF0B558-09AA-41E0-9510-8A38F3EA9554Q35589969-8B206696-5C1F-481B-8E95-F65C93DDF3FFQ35688547-C7ED0EF3-206A-4240-B62C-2AE119FD19C6Q35995170-3F18CC0F-28D3-435D-9ADB-540C3BC0A824Q36279074-048E652A-4A64-4A0A-AB1A-191B8DAFDE4BQ36404600-3B2E694D-EC3E-473C-96D9-BDDD4AE4F5E4Q36573262-AADD6711-CB0F-4856-8A69-F550A25E7E98Q36578070-760844AC-48CF-4600-ACEB-6DD355BFD602Q36652680-F272E709-3E6E-4C76-B00C-F18FD6BEB416Q37094439-7F1408B1-D0BC-4510-BBE1-1D315D43EAC3Q37157271-66252A41-B043-458B-81F3-1DB679ACE4C3Q37314261-0B4B9ECF-6F96-49DF-815B-43C32ABFD4C1Q37325606-C3A7BD7C-F4AB-469A-8197-AE6C7F39F6DCQ37409042-084DE5EE-8A8C-47C6-BAD0-BD849CAB692EQ37606401-964043EE-CE4A-4F94-9519-994FA7C7B331Q37677214-69AAAECB-085C-4CD6-A915-3913B4544F09Q37813449-5CC92ABF-99AF-4026-997B-749F3F9832C8Q38096571-21366FAB-C021-4E32-AFE6-2353E62829A5Q38245693-8B132DBD-D2D7-42FD-A864-F56D9ABA0C72Q38272259-A49E61E4-58AD-41C9-8649-18BF313AE2CCQ38798292-CE36ED72-4366-490E-917F-62241F64B34AQ39301963-C5516BF4-FA16-4BEA-BAD0-2C0C93DF590AQ41291977-5F166FC3-28B0-4092-8577-4FA01F989B1EQ44349161-178437A4-7FF4-41BA-B044-829796A77E09Q44392711-843022A9-FFA1-446B-899D-FDF3A9F55622Q47099872-49119734-D43E-42FD-991F-8A9F4869F402Q49957316-16D0A5D9-06C9-4EAC-96D2-BBCE08B228CA
P2860
The pharmacological treatment of opioid addiction--a clinical perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The pharmacological treatment of opioid addiction--a clinical perspective.
@en
The pharmacological treatment of opioid addiction--a clinical perspective.
@nl
type
label
The pharmacological treatment of opioid addiction--a clinical perspective.
@en
The pharmacological treatment of opioid addiction--a clinical perspective.
@nl
prefLabel
The pharmacological treatment of opioid addiction--a clinical perspective.
@en
The pharmacological treatment of opioid addiction--a clinical perspective.
@nl
P2093
P2860
P1476
The pharmacological treatment of opioid addiction--a clinical perspective.
@en
P2093
Helge Waal
Jorgen Bramness
Michael Gossop
Philipp Lobmaier
P2860
P2888
P304
P356
10.1007/S00228-010-0793-6
P577
2010-02-19T00:00:00Z